704. Deputy Ken O'Flynn asked the Minister for Health whether an increase in hours for a staff member in a work sharing arrangement counts against a health region's approved whole time equivalent ceiling under the pay and numbers strategy; whether health regions have been instructed to refuse or defer such increases to remain within that ceiling; and if she will make a statement on the matter. [70583/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
705. Deputy Charles Ward asked the Minister for Health the number of persons with type 1 Diabetes currently receiving insulin-pump therapy through the Public Health Service by adults and children and by Hospital at which their Diabetes care is provided in the years of 2025 and to date in 2026, in tabular form. [70605/26]
706. Deputy Charles Ward asked the Minister for Health the amount of funding allocated towards research into multiple sulfatase deficiency in each of the years of 2025 and to date in 2026, in tabular form. [70602/26]
707. Deputy Charles Ward asked the Minister for Health the number of WTE consultant radiologists, advanced nurse practitioners and radiographers posts filled within BreastCheck Service as of 21 September 2026; and if she will provide the same figures as of 30 September 2023, in tabular form. [70601/26]
708. Deputy Charles Ward asked the Minister for Health the number of WTE public health nurses based at Stranorlar Primary Care Centre, Donegal as of 21 September 2026. [70598/26]
709. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 68927/26, the name and grade of the officer in each HSE health region with responsibility for ensuring that pre-employment checks, including Garda vetting, overseas police clearance, occupational health clearance and English-language competency, are completed before a doctor commences employment, in tabular form; and if a stat…
710. Deputy Ken O'Flynn asked the Minister for Health the date on which Cork University Hospital sought approval to fill the vacant clinical nurse specialist post supporting skin cancer surveillance; the reason national approval has not issued in the seven months since the post became vacant; when a decision will be made; and if she will make a statement on the matter. [70656/26]
711. Deputy Ken O'Flynn asked the Minister for Health the arrangements now in place at Cork University Hospital for patients at elevated risk of melanoma who have no previous skin cancer diagnosis but were previously under surveillance in the discontinued service; and if she will make a statement on the matter. [70654/26]
712. Deputy Ken O'Flynn asked the Minister for Health the number of patients under active surveillance in the pigmented lesion service at Cork University Hospital at the time of its cessation; the number subsequently transferred to other clinicians; the number discharged to GP care; the number who received written notice of the change; and if she will make a statement on the matter. [70653/26]
713. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 65824/26, if the HSE operates a written protocol or policy on succession or continuity planning for established clinical services on the retirement of a Consultant; if so, if she will publish same; if not, if she will direct that one be developed; and if she will make a statement on the matter. [70651/26]
714. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 62012/26,which stated that an external review of CHI contained 13 recommendations and that 45 actions were identified in the CHI Implementation Plan, the number of those 45 actions completed; the number in progress; the number not yet commenced, respectively, as of the latest date for which data is available; and if she will m…
715. Deputy Ken O'Flynn asked the Minister for Health if a successor to the National Skin Cancer Prevention Plan 2023 to 2026 is being prepared; if it will address surveillance of high-risk individuals; the expected publication date; and if she will make a statement on the matter. [70659/26]
716. Deputy Ken O'Flynn asked the Minister for Health the number of Clinical Nurse Specialist and Advanced Nurse Practitioner posts in the HSE South West region identified as priority vacancies and currently awaiting national HSE approval to recruit, by hospital and specialty; and if she will make a statement on the matter. [70657/26]
717. Deputy Ken O'Flynn asked the Minister for Health whether the external review of CHI referenced in the HSE reply to PQ Ref 62012/26 has been shared with the Board of CHI, the National Paediatric Hospital Development Board, or HIQA; and if she will make a statement on the matter. [70669/26]
718. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 62012/26, whether she has personally received and read the external review of CHI referenced in the HSE reply; whether she will commit to publishing the review, or a redacted version or executive summary of it, once the new children's hospital has opened; the reason a redacted version cannot be published now, given that redact…
719. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 62012/26, the number of actions from the CHI Implementation Plan that have "transitioned" into the operational, commissioning, governance and clinical integration workstreams; the target completion date for each such action; the body responsible for monitoring their completion; and if she will make a statement on the matter. […
720. Deputy Seán Kyne asked the Minister for Health the current status of the HSE's assessment of dupilumab for eosinophilic oesophagitis; and the expected date of a decision on the use of this medicine. [70680/26]
721. Deputy Seán Kyne asked the Minister for Health the action the HSE and HPRA are taking on the current supply shortage of budesonide orodispersible tablets in the State. [70677/26]
722. Deputy Ken O'Flynn asked the Minister for Health the identity of the person or organisation that carried out the external review of CHI referenced in the HSE reply to PQ Ref 62012/26; the date on which the review was commissioned and the date on which it was completed; the total cost of the review; and if she will make a statement on the matter. [70676/26]
723. Deputy Seán Kyne asked the Minister for Health the current status of the HSE's full health technology assessment of budesonide orodispersible tablets (Jorveza, NCPE HTA ID 24014) for eosinophilic oesophagitis, commissioned on 25 June 2024; the reason no outcome has been published in over two years; and the expected date of a reimbursement decision. [70675/26]
724. Deputy Seán Kyne asked the Minister for Health whether the free HRT scheme will be extended to cover hormone replacement therapy for patients with congenital or permanent endocrine conditions, including testosterone replacement for Klinefelter syndrome. [70683/26]
725. Deputy Máire Devine asked the Minister for Health the position regarding the administration of the auto-enrolment scheme for an organisation grant-aided by the HSE (details supplied), who were advised that the costs associated with the scheme would be funded by the State/HSE however, no reimbursement or additional funding has been provided. [70482/26]
726. Deputy Jen Cummins asked the Minister for Health for an update on a property (details supplied). [69744/26]
727. Deputy Liam Quaide asked the Minister for Health the number of children with an intellectual disability who are currently inpatients in acute or other hospitals where the admission or continued hospital stay is related to significant behavioural challenges or distress levels; the number of these children who have been in hospital for more than one, three and six months, by health region; and the number who remai…
161. Deputy Barry Heneghan asked the Minister for Health the measures being taken to ensure equitable access to care for people living with pulmonary fibrosis across all regions, including access to specialist multidisciplinary teams, timely diagnostics, pulmonary rehabilitation, oxygen services and appropriate community-based care; and whether gaps in regional provision have been examined. [69022/26]